News - Vaccines


Current filters:


Popular Filters

251 to 274 of 274 results

GlaxoSmithKline takes full control of Neptunus JV; links with Arecor on vaccines


In one of two pieces of vaccine-related news yesterday, GlaxoSmithKline (LSE: GSK) said it is acquiring…

ArecorGlaxoSmithKlineLicensingMergers & AcquisitionsPharmaceuticalShenzhen NeptunusVaccines

Donors commit $4.3 billion in vaccine funding to achieve historic milestone for GAVI Alliance


Major public and private donors achieved a milestone in global health by committing funding to immunize…


Novartis says Bexsero shows significant potential against meningococcal serogroup B infections


Swiss drug major Novartis (NVN: VX) says that new data from a pivotal study in more than 1,800 infants…

Antibiotics and Infectious diseasesBexseroNovartisPharmaceuticalResearchVaccines

PATH MVI partners with GSK and Crucell to develop second-generation vaccine against malaria


The PATH Malaria Vaccine Initiative (MVI) announced today that it has entered into a collaboration with…

CrucellGlaxoSmithKlineJohnson & JohnsonPharmaceuticalResearchTropical diseasesVaccines

Pharma majors slash vaccine prices to poorest countries


Several pharmaceutical majors, including the UK’s GlaxoSmithKline (LSE: GSK), US giants Merck &…

GardasilGlaxoSmithKlineGlobalJohnson & JohnsonMerck & CoPharmaceuticalPricingRotarixSanofiSanofi PasteurVaccines

China human vaccine market hit $1.59 billion in 2010


With the improvement of economy and people's disease prevention awareness, China's human vaccine market…

Asia-PacificMarkets & MarketingPharmaceuticalVaccines

UNICEF decision to make vaccine prices public likely to have major impact on developing country markets


In a bid to increase transparency and stimulate competition to bring down the prices of vaccines needed…


Vaccine side effects under the microscope in Australia


Australia’s Gillard government yesterday released an independent assessment of the nation's management…


Research-based Pharma welcomes outcome on vaccines, fake - and affordable - medicines diseases at WHA


As one of the 189 non-governmental organizations (NGOs) in official relations with the World Health Organization…


GAVI commits $100 million to fight meningitis A


The GAVI Alliance has committed $100 million to help tackle meningitis A in Cameroon, Chad and Nigeria,…

FinancialMenAfriVacPharmaceuticalRest of the WorldVaccines

Despite boost to Australia mental health funding, latest schizophrenia drug still blocked


As part of its latest budget announcement, Australia’s federal government has allocated A$2.2 billion…


Pfizer’s Prevnar 13 meets all endpoints in pivotal Ph III trials on over 50s


Global drugs behemoth Pfizer (NYSE: PFE) says that the data from its two pivotal Phase III immunogenicity…

PfizerPharmaceuticalPrevnarResearchRespiratory and PulmonaryVaccines

Italian HIV vaccine testing in SA; Australian scientists say insight into HIV immunity may lead to vaccine


Two pieces of unrelated news regarding HIV vaccines broke last week: one on a development from Italy…


Vaccine to halt Alzheimer's could be available within few years


A vaccine that has the potential to stop Alzheimer's disease progression could be available within a…

BiotechnologyCytos BiotechnologyNeurologicalNovartisPharmaceuticalResearchVaccines

Kaketsuken initiates second trial of flu vaccine using Vivalis EB66 cell line


Japan’s Chemo-Sero-Therapeutic Research Institute (Kaketsuken) has initiated the first human injection…

GlaxoSmithKlineKaketsukenPharmaceuticalResearchRespiratory and PulmonaryVaccinesVivalis

Transgene, ChronTech Pharma and Inovio to collaborate on hep C vaccine


France’s Transgene (Euronext Paris: FR0005175080) has signed a collaboration agreement with Sweden’s…

Anti-viralsChronTech PharmaInovio PharmaceuticalsPharmaceuticalResearchTransgeneVaccines

Cancer vaccines poised to reach $3 billion in sales by 2015


Research on cancer trends and development has identified cancer vaccines as a viable treatment option…

BiovaxIDBiovest InternationalMarkets & MarketingOncologyPharmaceuticalVaccines

EMA updates Rxing advice for GlaxoSmithKline’s Pandemrix reflecting possible narcolepsy link


The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended…


WHO claims landmark agreement to improve global preparedness for flu pandemics


The World Health Organization announced yesterday that, after a week of negotiations continued through…

GlobalLegalPharmaceuticalRegulationRespiratory and PulmonaryVaccines

251 to 274 of 274 results

Back to top